Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Phytosphingosine.
A long-chain sphingoid base that serves as a critical precursor to ceramides, exhibiting potent antimicrobial, anti-inflammatory, and skin-barrier restorative properties through the modulation of lipid signaling pathways.
122121
317.5 g/mol
4.6
(2S,3S,4R)-2-aminooctadecane-1,3,4-triol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Phytosphingosine across standard consumer modalities.
The high lipophilicity and low aqueous solubility of phytosphingosine necessitate lipid-based carriers or micronization to ensure adequate gastrointestinal absorption.
Incorporating phytosphingosine into pectin matrices is challenging due to its waxy texture and potential to disrupt the gel network integrity at standard processing temperatures.
The low potency-to-weight ratio and hydrophobic nature of phytosphingosine limit the achievable payload within the thin-film polymer matrix without compromising mechanical flexibility.
Ready to launch a product featuring Phytosphingosine? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Phytosphingosine extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Phytosphingosine payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation